Brief: Compugroup Medical Confirms Its Guidance For FY 2025
April 30 (Reuters) - COMPUGROUP MEDICAL SE & CO KGAA COP1n.DE: COMPUGROUP MEDICAL Q1 REVENUE EUR 286.2 MILLION COMPUGROUP MEDICAL Q1 ADJUSTED EPS EUR 0.35 COMPUGROUP MEDICAL Q1 FREE CASH FLOW EUR 78.3 MILLION COMPUGROUP MEDICAL SE & CO KGAA - CONFIRMS ITS GUIDANCE FOR FULL YEAR'S FINANCIAL FIGURES OF 2025 Q1 ADJUSTED EBITDA DECLINED BY 16 PERCENT TO EUR 51.1 MILLION (PY: EUR 60.7 MILLION) EBITDA MARGIN STOOD AT 18 PERCENT (PY: 21 PERCENT) Source text: ID:nEQ5mPVTja Further company coverage: [COP1n.DE] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on CompuGroup Medical SE & Co KgaA
See all newsBrief: Nagarro to replace CompuGroup in Germany's TecDax, Stratec in SDAX
Brief: Compugroup Medical Delisting Effective 24 June 2025
Brief: Compugroup Medical SE & Co KGaA - Issues Joint Reasoned Statement Recommending Shareholders To Accept Cvc's Public Delisting Offer
Brief: Cvc Capital Partners - Acceptance Period For Public Delisting Offer To Shareholders Of Compugroup Begins
Brief: Caesar Bidco Says Intends To Offer Cash Consideration In Amount Of Eur 22.00 Per CompuGroup Medical Share